GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

GLP-1 receptor agonists were originally developed in the early 2000s to treat type 2 diabetes.

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these ...

As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access. GLP ...

SHANGHAI, June 29 (Reuters) - Pfizer's ecnoglutide and Innovent Biologics' mazdutide have passed a preliminary review to be potentially included in China's basic medical insurance drug catalogue, a ...

A new review explores how GLP-1 receptor agonists may blunt alcohol and drug reward signals, opening a promising but still unproven path toward repurposed treatments for addiction. Review: The role of ...

Patients with cancer taking GLP-1 drugs alongside immunotherapy had better long-term survival and fewer immune-related side effects. A large real-world study found that patients with cancer who used ...

HCM causes the heart muscle to abnormally thicken, making it harder for the heart to pump blood effectively. According to the Centers for Disease Control, HCM affects roughly one in 500 people and is ...

Micrograph of a histological slide with cells stained with H&E, which makes cytoplasm pink and nuclei navy. Many cells have large, round, unstained regions; these are triglycerides. A liver biopsy ...

GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly lower long term risk of knee replacement surgery as a result of ...